Affiliations

NYBA

Australia Biotech

BioMelbourne

Lab To Wall Street

Industry News

Browse news archive by:
Date | Company Name | Country/States

Dec. Nov. Oct. Sept. Aug. July
June May April March Feb. Jan.

July 2007:

July 30th:
HealthLinx Teams With University of Virginia In Treatment For Acute Respiratory Distress Syndrome
read article >

July 26th:
Biota's Relenza At $11,1 Million In Royalties
read article >

July 26th:
Biosignal Partners To Penetrate Japanese Market
read article >

July 25th:
Progen Pharmaceuticals Approved For Listing On NASDAQ
read article >

July 25th:
Peter Brooks To Join Bone Medical Board
read article >

July 24th:
Solbec Pharmaceuticals Announces Appointment Of Director
read article >

July 24th:
Biosignal Oil & Gas Anti-bacterial To Be Tested In Oil Field Conditions
read article >

July 18th:
Benitec Wins Crucial Court Judgement In US Federal Court Of Appeals
read article >

July 18th:
Bone Medical Appoints New Managing Director
read article >

July 18th:
CogState Signs Its First Agreement with AstraZeneca
read article >

July 9th:
Pharmaxis Files For Aridol Approval In Korea First Move Into Asia
read article >

July 5th:
Pharmaaxis Completes Phase III Bronchiectasis Trial
read article >

July 5th:
HalcyGen Anti-Fungal Drug Enters Phase III Trial Tn 2007/08 After Passing Clinical Test
read article >

July 2nd:
Living Cell Technologies Enhances U.S. Capabilities: Appoints The Channel Group to Lead Commercial and Capital Markets Initiatives
read article >

July 2nd:
Biosignal Appoints Interim CEO
read article >

July 2nd:
CEO Of Benitec Joins The Company's Board Of Directors
read article >

Dec. Nov. Oct. Sept. Aug. July
June May April March Feb. Jan.

  May 28th, 2009:
Arana Therapeutics Board Changes

May 6th, 2009:
Circadian Scientific Advisory Board Chairman, Professor Kari Alitalo, Wins Prestigious Award for Biomedical Research

May 5th, 2009:
Living Cell Technologies Reports Insulin Independence in Two Patients Following Recent Implants of DIABECELL® in Diabetes Clinical Trial

November 3rd:
FDA Accepts Arana's Anti-inflammatory IND

September 4th:
Cytopia Commences Second Phase II Study in Brain Cancer

September 4th:
Pharmaxis Announces Second Pivotal Phase 3 Trial in Cystic Fibrosis Begins

August 6th:
Xenome Strengthens Board with Two New Appointments

August 6th:
Ciba Elects to Cease Industrial Product Evaluations

June 24th:
New Pharmaxis Board Appointment

April 29th:
Benitec secures further rights to HIV Therapeutic

more industry news >
 


osullivanpllc.com  

Disclaimer